Concepedia

Makonen Belema

MB

22

Publications

1.9K

Citations

18

H-Index

1994

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Canada)

Makonen Belema is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1994–2023

22

Publications

22

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 929 citations · Full text

, , +10

Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect

Makonen Belema, Nicholas A. Meanwell · Journal of Medicinal Chemistry · 2014 · 107 citations

, , +12

Chiral Aziridinyl Radicals:  An Application to the Synthesis of the Core Nucleus of FR-900482

Frederick E. Ziegler, Makonen Belema · The Journal of Organic Chemistry · 1997 · 102 citations

, , +14

Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

Makonen Belema, Van N. Nguyen, Carol Bachand et al. · Journal of Medicinal Chemistry · 2014 · 87 citations · Full text

Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ

Bruno P. Klaholz, A. Mitschler, Makonen Belema et al. · Proceedings of the National Academy of Sciences · 2000 · 84 citations · Full text

, , +21

Rows per page

1–5 of 22